カテゴリー： Market Monitor Global, 世界, 医療/バイオ

抗ラクダ科VHH抗体の世界市場見通し2023年-2029年

◆英語タイトル：Anti-Camelid VHH Antibody Market, Global Outlook and Forecast 2023-2029

Market Monitor Globalが発行した調査報告書（MMG23JU5671）◆商品コード：MMG23JU5671
◆発行会社（リサーチ会社）：Market Monitor Global
◆発行日：2023年6月
◆ページ数：68
◆レポート形式：英語 / PDF
◆納品方法：Eメール（受注後2-3営業日）
◆調査対象地域：グローバル、北米、アメリカ、ヨーロッパ、アジア、日本、中国、東南アジア、インド、南米、中東・アフリカなど
◆産業分野：医薬品＆医療
◆販売価格オプション（消費税別）
Single User（1名様閲覧用）USD3,250 ⇒換算￥494,000見積依頼/購入/質問フォーム
Multi User（20名様閲覧用）USD4,225 ⇒換算￥642,200見積依頼/購入/質問フォーム
Enterprise User（閲覧人数制限なし）USD4,875 ⇒換算￥741,000見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いに変更可）
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。

❖ レポートの概要 ❖

Global Anti-Camelid VHH Antibody Market 調査レポートは次の情報を含め、グローバルにおけるの抗ラクダ科VHH抗体市場規模と予測を収録しています。・世界の抗ラクダ科VHH抗体市場：売上、2018年-2023年、2024年-2029年
・世界の抗ラクダ科VHH抗体市場：販売量、2018年-2023年、2024年-2029年
・世界のトップ5企業、2022年

世界の抗ラクダ科VHH抗体市場は2022年に000Mドルと評価され、予測期間中に000％のCAGRで2029年までに000Mドルに達すると予測されています。アメリカ市場は2022年に000Mドルと推定されており、中国は2029年までに000Mドルに達すると予測されています。「ウェスタンブロット」セグメントは今後6年間、000%の年平均成長率で2029年までに000Mドルに成長すると予測されています。

抗ラクダ科VHH抗体のグローバル主要企業は、Genscript Biotech Corporation、 Rockland Immunochemicals, Inc.、 ABclonal、 Eurogentec、 Jackson ImmunoResearch、 Southern Biotech、 LSBio、 Stratechなどです。2022年にトップ5企業がグローバル売上シェアの約000%を占めています。

マーケットモニターグローバル社は、抗ラクダ科VHH抗体のメーカー、サプライヤー、流通業者、および業界の専門家を調査しました。これには、販売量、売上、需要、価格変動、製品タイプ、最近の動向と計画、産業トレンド、成長要因、課題、阻害要因、潜在的なリスクなどが含まれます。

【セグメント別マーケット分析】

世界の抗ラクダ科VHH抗体市場：タイプ別、2018年-2023年、2024年-2029年
世界の抗ラクダ科VHH抗体市場：タイプ別市場シェア、2022年
・ウェスタンブロット、ELISA

世界の抗ラクダ科VHH抗体市場：用途別、2018年-2023年、2024年-2029年
世界の抗ラクダ科VHH抗体市場：用途別市場シェア、2022年
・細胞&遺伝子治療、遺伝子診断、その他

世界の抗ラクダ科VHH抗体市場：地域・国別、2018年-2023年、2024年-2029年
世界の抗ラクダ科VHH抗体市場：地域別市場シェア、2022年
・北米：アメリカ、カナダ、メキシコ
・ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア
・アジア：中国、日本、韓国、東南アジア、インド
・南米：ブラジル、アルゼンチン
・中東・アフリカ：トルコ、イスラエル、サウジアラビア、UAE

【競争分析】

また、当レポートは主要な参入企業の分析を提供します。
・主要企業における抗ラクダ科VHH抗体のグローバル売上、2018年-2023年
・主要企業における抗ラクダ科VHH抗体のグローバル売上シェア、2022年
・主要企業における抗ラクダ科VHH抗体のグローバル販売量、2018年-2023年
・主要企業における抗ラクダ科VHH抗体のグローバル販売量シェア、2022年

さらに、当レポートは主要企業の情報を提示します。
Genscript Biotech Corporation、 Rockland Immunochemicals, Inc.、 ABclonal、 Eurogentec、 Jackson ImmunoResearch、 Southern Biotech、 LSBio、 Stratech

*************************************************************

・調査・分析レポートの概要
抗ラクダ科VHH抗体市場の定義
市場セグメント
世界の抗ラクダ科VHH抗体市場概要
当レポートの特徴・ベネフィット
調査手法と情報源

・世界の抗ラクダ科VHH抗体市場規模
世界の抗ラクダ科VHH抗体市場規模：2022年 VS 2029年
世界の抗ラクダ科VHH抗体市場規模と予測 2018年-2029年

・競争状況
グローバルトップ企業
売上ベースでのグローバルトップ企業
企業別グローバルでの抗ラクダ科VHH抗体の売上
グローバルトップ3およびトップ5企業、2022年売上ベース
グローバル企業の抗ラクダ科VHH抗体製品タイプ
グローバルにおけるティア1、ティア2、ティア3企業

・タイプ別市場分析
タイプ区分：ウェスタンブロット、ELISA
抗ラクダ科VHH抗体のタイプ別グローバル売上・予測

・用途別市場分析
用途区分：細胞&遺伝子治療、遺伝子診断、その他
抗ラクダ科VHH抗体の用途別グローバル売上・予測

・地域別市場分析
地域別抗ラクダ科VHH抗体市場規模 2022年と2029年
地域別抗ラクダ科VHH抗体売上・予測
北米市場：アメリカ、カナダ、メキシコ
ヨーロッパ市場：ドイツ、フランス、イギリス、イタリア、ロシア
アジア市場：中国、日本、韓国、東南アジア、インド
南米市場：ブラジル、アルゼンチン
中東・アフリカ市場：トルコ、イスラエル、サウジアラビア、UAE

・主要企業の情報（企業概要、事業概要、主要製品、売上、ニュースなど）
Genscript Biotech Corporation、 Rockland Immunochemicals, Inc.、 ABclonal、 Eurogentec、 Jackson ImmunoResearch、 Southern Biotech、 LSBio、 Stratech
...

This report aims to provide a comprehensive presentation of the global market for Anti-Camelid VHH Antibody, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Anti-Camelid VHH Antibody. This report contains market size and forecasts of Anti-Camelid VHH Antibody in global, including the following market information:
Global Anti-Camelid VHH Antibody Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global top five companies in 2022 (%)
The global Anti-Camelid VHH Antibody market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is to reach $ Million.
Western Blot Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Anti-Camelid VHH Antibody include Genscript Biotech Corporation, Rockland Immunochemicals, Inc., ABclonal, Eurogentec, Jackson ImmunoResearch, Southern Biotech, LSBio and Stratech, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Anti-Camelid VHH Antibody companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Anti-Camelid VHH Antibody Market, by Type, 2018-2023, 2024-2029 ($ millions)
Global Anti-Camelid VHH Antibody Market Segment Percentages, by Type, 2022 (%)
Western Blot
ELISA
Global Anti-Camelid VHH Antibody Market, by Application, 2018-2023, 2024-2029 ($ millions)
Global Anti-Camelid VHH Antibody Market Segment Percentages, by Application, 2022 (%)
Cell and Gene Therapy
Genetic Diagnosis
Others
Global Anti-Camelid VHH Antibody Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions)
Global Anti-Camelid VHH Antibody Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Anti-Camelid VHH Antibody revenues in global market, 2018-2023 (estimated), ($ millions)
Key companies Anti-Camelid VHH Antibody revenues share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Genscript Biotech Corporation
Rockland Immunochemicals, Inc.
ABclonal
Eurogentec
Jackson ImmunoResearch
Southern Biotech
LSBio
Stratech
Outline of Major Chapters:
Chapter 1: Introduces the definition of Anti-Camelid VHH Antibody, market overview.
Chapter 2: Global Anti-Camelid VHH Antibody market size in revenue.
Chapter 3: Detailed analysis of Anti-Camelid VHH Antibody company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Anti-Camelid VHH Antibody in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.

❖ レポートの目次 ❖

1 Introduction to Research & Analysis Reports
1.1 Anti-Camelid VHH Antibody Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Anti-Camelid VHH Antibody Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Anti-Camelid VHH Antibody Overall Market Size
2.1 Global Anti-Camelid VHH Antibody Market Size: 2022 VS 2029
2.2 Global Anti-Camelid VHH Antibody Market Size, Prospects & Forecasts: 2018-2029
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Anti-Camelid VHH Antibody Players in Global Market
3.2 Top Global Anti-Camelid VHH Antibody Companies Ranked by Revenue
3.3 Global Anti-Camelid VHH Antibody Revenue by Companies
3.4 Top 3 and Top 5 Anti-Camelid VHH Antibody Companies in Global Market, by Revenue in 2022
3.5 Global Companies Anti-Camelid VHH Antibody Product Type
3.6 Tier 1, Tier 2 and Tier 3 Anti-Camelid VHH Antibody Players in Global Market
3.6.1 List of Global Tier 1 Anti-Camelid VHH Antibody Companies
3.6.2 List of Global Tier 2 and Tier 3 Anti-Camelid VHH Antibody Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type – Global Anti-Camelid VHH Antibody Market Size Markets, 2022 & 2029
4.1.2 Western Blot
4.1.3 ELISA
4.2 By Type – Global Anti-Camelid VHH Antibody Revenue & Forecasts
4.2.1 By Type – Global Anti-Camelid VHH Antibody Revenue, 2018-2023
4.2.2 By Type – Global Anti-Camelid VHH Antibody Revenue, 2024-2029
4.2.3 By Type – Global Anti-Camelid VHH Antibody Revenue Market Share, 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application – Global Anti-Camelid VHH Antibody Market Size, 2022 & 2029
5.1.2 Cell and Gene Therapy
5.1.3 Genetic Diagnosis
5.1.4 Others
5.2 By Application – Global Anti-Camelid VHH Antibody Revenue & Forecasts
5.2.1 By Application – Global Anti-Camelid VHH Antibody Revenue, 2018-2023
5.2.2 By Application – Global Anti-Camelid VHH Antibody Revenue, 2024-2029
5.2.3 By Application – Global Anti-Camelid VHH Antibody Revenue Market Share, 2018-2029
6 Sights by Region
6.1 By Region – Global Anti-Camelid VHH Antibody Market Size, 2022 & 2029
6.2 By Region – Global Anti-Camelid VHH Antibody Revenue & Forecasts
6.2.1 By Region – Global Anti-Camelid VHH Antibody Revenue, 2018-2023
6.2.2 By Region – Global Anti-Camelid VHH Antibody Revenue, 2024-2029
6.2.3 By Region – Global Anti-Camelid VHH Antibody Revenue Market Share, 2018-2029
6.3 North America
6.3.1 By Country – North America Anti-Camelid VHH Antibody Revenue, 2018-2029
6.3.2 US Anti-Camelid VHH Antibody Market Size, 2018-2029
6.3.3 Canada Anti-Camelid VHH Antibody Market Size, 2018-2029
6.3.4 Mexico Anti-Camelid VHH Antibody Market Size, 2018-2029
6.4 Europe
6.4.1 By Country – Europe Anti-Camelid VHH Antibody Revenue, 2018-2029
6.4.2 Germany Anti-Camelid VHH Antibody Market Size, 2018-2029
6.4.3 France Anti-Camelid VHH Antibody Market Size, 2018-2029
6.4.4 U.K. Anti-Camelid VHH Antibody Market Size, 2018-2029
6.4.5 Italy Anti-Camelid VHH Antibody Market Size, 2018-2029
6.4.6 Russia Anti-Camelid VHH Antibody Market Size, 2018-2029
6.4.7 Nordic Countries Anti-Camelid VHH Antibody Market Size, 2018-2029
6.4.8 Benelux Anti-Camelid VHH Antibody Market Size, 2018-2029
6.5 Asia
6.5.1 By Region – Asia Anti-Camelid VHH Antibody Revenue, 2018-2029
6.5.2 China Anti-Camelid VHH Antibody Market Size, 2018-2029
6.5.3 Japan Anti-Camelid VHH Antibody Market Size, 2018-2029
6.5.4 South Korea Anti-Camelid VHH Antibody Market Size, 2018-2029
6.5.5 Southeast Asia Anti-Camelid VHH Antibody Market Size, 2018-2029
6.5.6 India Anti-Camelid VHH Antibody Market Size, 2018-2029
6.6 South America
6.6.1 By Country – South America Anti-Camelid VHH Antibody Revenue, 2018-2029
6.6.2 Brazil Anti-Camelid VHH Antibody Market Size, 2018-2029
6.6.3 Argentina Anti-Camelid VHH Antibody Market Size, 2018-2029
6.7 Middle East & Africa
6.7.1 By Country – Middle East & Africa Anti-Camelid VHH Antibody Revenue, 2018-2029
6.7.2 Turkey Anti-Camelid VHH Antibody Market Size, 2018-2029
6.7.3 Israel Anti-Camelid VHH Antibody Market Size, 2018-2029
6.7.4 Saudi Arabia Anti-Camelid VHH Antibody Market Size, 2018-2029
6.7.5 UAE Anti-Camelid VHH Antibody Market Size, 2018-2029
7 Anti-Camelid VHH Antibody Companies Profiles
7.1 Genscript Biotech Corporation
7.1.1 Genscript Biotech Corporation Company Summary
7.1.2 Genscript Biotech Corporation Business Overview
7.1.3 Genscript Biotech Corporation Anti-Camelid VHH Antibody Major Product Offerings
7.1.4 Genscript Biotech Corporation Anti-Camelid VHH Antibody Revenue in Global Market (2018-2023)
7.1.5 Genscript Biotech Corporation Key News & Latest Developments
7.2 Rockland Immunochemicals, Inc.
7.2.1 Rockland Immunochemicals, Inc. Company Summary
7.2.2 Rockland Immunochemicals, Inc. Business Overview
7.2.3 Rockland Immunochemicals, Inc. Anti-Camelid VHH Antibody Major Product Offerings
7.2.4 Rockland Immunochemicals, Inc. Anti-Camelid VHH Antibody Revenue in Global Market (2018-2023)
7.2.5 Rockland Immunochemicals, Inc. Key News & Latest Developments
7.3 ABclonal
7.3.1 ABclonal Company Summary
7.3.2 ABclonal Business Overview
7.3.3 ABclonal Anti-Camelid VHH Antibody Major Product Offerings
7.3.4 ABclonal Anti-Camelid VHH Antibody Revenue in Global Market (2018-2023)
7.3.5 ABclonal Key News & Latest Developments
7.4 Eurogentec
7.4.1 Eurogentec Company Summary
7.4.2 Eurogentec Business Overview
7.4.3 Eurogentec Anti-Camelid VHH Antibody Major Product Offerings
7.4.4 Eurogentec Anti-Camelid VHH Antibody Revenue in Global Market (2018-2023)
7.4.5 Eurogentec Key News & Latest Developments
7.5 Jackson ImmunoResearch
7.5.1 Jackson ImmunoResearch Company Summary
7.5.2 Jackson ImmunoResearch Business Overview
7.5.3 Jackson ImmunoResearch Anti-Camelid VHH Antibody Major Product Offerings
7.5.4 Jackson ImmunoResearch Anti-Camelid VHH Antibody Revenue in Global Market (2018-2023)
7.5.5 Jackson ImmunoResearch Key News & Latest Developments
7.6 Southern Biotech
7.6.1 Southern Biotech Company Summary
7.6.2 Southern Biotech Business Overview
7.6.3 Southern Biotech Anti-Camelid VHH Antibody Major Product Offerings
7.6.4 Southern Biotech Anti-Camelid VHH Antibody Revenue in Global Market (2018-2023)
7.6.5 Southern Biotech Key News & Latest Developments
7.7 LSBio
7.7.1 LSBio Company Summary
7.7.2 LSBio Business Overview
7.7.3 LSBio Anti-Camelid VHH Antibody Major Product Offerings
7.7.4 LSBio Anti-Camelid VHH Antibody Revenue in Global Market (2018-2023)
7.7.5 LSBio Key News & Latest Developments
7.8 Stratech
7.8.1 Stratech Company Summary
7.8.2 Stratech Business Overview
7.8.3 Stratech Anti-Camelid VHH Antibody Major Product Offerings
7.8.4 Stratech Anti-Camelid VHH Antibody Revenue in Global Market (2018-2023)
7.8.5 Stratech Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer

List of Tables
Table 1. Anti-Camelid VHH Antibody Market Opportunities & Trends in Global Market
Table 2. Anti-Camelid VHH Antibody Market Drivers in Global Market
Table 3. Anti-Camelid VHH Antibody Market Restraints in Global Market
Table 4. Key Players of Anti-Camelid VHH Antibody in Global Market
Table 5. Top Anti-Camelid VHH Antibody Players in Global Market, Ranking by Revenue (2022)
Table 6. Global Anti-Camelid VHH Antibody Revenue by Companies, (US$, Mn), 2018-2023
Table 7. Global Anti-Camelid VHH Antibody Revenue Share by Companies, 2018-2023
Table 8. Global Companies Anti-Camelid VHH Antibody Product Type
Table 9. List of Global Tier 1 Anti-Camelid VHH Antibody Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Anti-Camelid VHH Antibody Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type – Global Anti-Camelid VHH Antibody Revenue, (US$, Mn), 2022 & 2029
Table 12. By Type - Anti-Camelid VHH Antibody Revenue in Global (US$, Mn), 2018-2023
Table 13. By Type - Anti-Camelid VHH Antibody Revenue in Global (US$, Mn), 2024-2029
Table 14. By Application – Global Anti-Camelid VHH Antibody Revenue, (US$, Mn), 2022 & 2029
Table 15. By Application - Anti-Camelid VHH Antibody Revenue in Global (US$, Mn), 2018-2023
Table 16. By Application - Anti-Camelid VHH Antibody Revenue in Global (US$, Mn), 2024-2029
Table 17. By Region – Global Anti-Camelid VHH Antibody Revenue, (US$, Mn), 2022 & 2029
Table 18. By Region - Global Anti-Camelid VHH Antibody Revenue (US$, Mn), 2018-2023
Table 19. By Region - Global Anti-Camelid VHH Antibody Revenue (US$, Mn), 2024-2029
Table 20. By Country - North America Anti-Camelid VHH Antibody Revenue, (US$, Mn), 2018-2023
Table 21. By Country - North America Anti-Camelid VHH Antibody Revenue, (US$, Mn), 2024-2029
Table 22. By Country - Europe Anti-Camelid VHH Antibody Revenue, (US$, Mn), 2018-2023
Table 23. By Country - Europe Anti-Camelid VHH Antibody Revenue, (US$, Mn), 2024-2029
Table 24. By Region - Asia Anti-Camelid VHH Antibody Revenue, (US$, Mn), 2018-2023
Table 25. By Region - Asia Anti-Camelid VHH Antibody Revenue, (US$, Mn), 2024-2029
Table 26. By Country - South America Anti-Camelid VHH Antibody Revenue, (US$, Mn), 2018-2023
Table 27. By Country - South America Anti-Camelid VHH Antibody Revenue, (US$, Mn), 2024-2029
Table 28. By Country - Middle East & Africa Anti-Camelid VHH Antibody Revenue, (US$, Mn), 2018-2023
Table 29. By Country - Middle East & Africa Anti-Camelid VHH Antibody Revenue, (US$, Mn), 2024-2029
Table 30. Genscript Biotech Corporation Company Summary
Table 31. Genscript Biotech Corporation Anti-Camelid VHH Antibody Product Offerings
Table 32. Genscript Biotech Corporation Anti-Camelid VHH Antibody Revenue (US$, Mn) & (2018-2023)
Table 33. Genscript Biotech Corporation Key News & Latest Developments
Table 34. Rockland Immunochemicals, Inc. Company Summary
Table 35. Rockland Immunochemicals, Inc. Anti-Camelid VHH Antibody Product Offerings
Table 36. Rockland Immunochemicals, Inc. Anti-Camelid VHH Antibody Revenue (US$, Mn) & (2018-2023)
Table 37. Rockland Immunochemicals, Inc. Key News & Latest Developments
Table 38. ABclonal Company Summary
Table 39. ABclonal Anti-Camelid VHH Antibody Product Offerings
Table 40. ABclonal Anti-Camelid VHH Antibody Revenue (US$, Mn) & (2018-2023)
Table 41. ABclonal Key News & Latest Developments
Table 42. Eurogentec Company Summary
Table 43. Eurogentec Anti-Camelid VHH Antibody Product Offerings
Table 44. Eurogentec Anti-Camelid VHH Antibody Revenue (US$, Mn) & (2018-2023)
Table 45. Eurogentec Key News & Latest Developments
Table 46. Jackson ImmunoResearch Company Summary
Table 47. Jackson ImmunoResearch Anti-Camelid VHH Antibody Product Offerings
Table 48. Jackson ImmunoResearch Anti-Camelid VHH Antibody Revenue (US$, Mn) & (2018-2023)
Table 49. Jackson ImmunoResearch Key News & Latest Developments
Table 50. Southern Biotech Company Summary
Table 51. Southern Biotech Anti-Camelid VHH Antibody Product Offerings
Table 52. Southern Biotech Anti-Camelid VHH Antibody Revenue (US$, Mn) & (2018-2023)
Table 53. Southern Biotech Key News & Latest Developments
Table 54. LSBio Company Summary
Table 55. LSBio Anti-Camelid VHH Antibody Product Offerings
Table 56. LSBio Anti-Camelid VHH Antibody Revenue (US$, Mn) & (2018-2023)
Table 57. LSBio Key News & Latest Developments
Table 58. Stratech Company Summary
Table 59. Stratech Anti-Camelid VHH Antibody Product Offerings
Table 60. Stratech Anti-Camelid VHH Antibody Revenue (US$, Mn) & (2018-2023)
Table 61. Stratech Key News & Latest Developments
List of Figures
Figure 1. Anti-Camelid VHH Antibody Segment by Type in 2022
Figure 2. Anti-Camelid VHH Antibody Segment by Application in 2022
Figure 3. Global Anti-Camelid VHH Antibody Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Anti-Camelid VHH Antibody Market Size: 2022 VS 2029 (US$, Mn)
Figure 6. Global Anti-Camelid VHH Antibody Revenue, 2018-2029 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Anti-Camelid VHH Antibody Revenue in 2022
Figure 8. By Type - Global Anti-Camelid VHH Antibody Revenue Market Share, 2018-2029
Figure 9. By Application - Global Anti-Camelid VHH Antibody Revenue Market Share, 2018-2029
Figure 10. By Type - Global Anti-Camelid VHH Antibody Revenue, (US$, Mn), 2022 & 2029
Figure 11. By Type - Global Anti-Camelid VHH Antibody Revenue Market Share, 2018-2029
Figure 12. By Application - Global Anti-Camelid VHH Antibody Revenue, (US$, Mn), 2022 & 2029
Figure 13. By Application - Global Anti-Camelid VHH Antibody Revenue Market Share, 2018-2029
Figure 14. By Region - Global Anti-Camelid VHH Antibody Revenue Market Share, 2018-2029
Figure 15. By Country - North America Anti-Camelid VHH Antibody Revenue Market Share, 2018-2029
Figure 16. US Anti-Camelid VHH Antibody Revenue, (US$, Mn), 2018-2029
Figure 17. Canada Anti-Camelid VHH Antibody Revenue, (US$, Mn), 2018-2029
Figure 18. Mexico Anti-Camelid VHH Antibody Revenue, (US$, Mn), 2018-2029
Figure 19. By Country - Europe Anti-Camelid VHH Antibody Revenue Market Share, 2018-2029
Figure 20. Germany Anti-Camelid VHH Antibody Revenue, (US$, Mn), 2018-2029
Figure 21. France Anti-Camelid VHH Antibody Revenue, (US$, Mn), 2018-2029
Figure 22. U.K. Anti-Camelid VHH Antibody Revenue, (US$, Mn), 2018-2029
Figure 23. Italy Anti-Camelid VHH Antibody Revenue, (US$, Mn), 2018-2029
Figure 24. Russia Anti-Camelid VHH Antibody Revenue, (US$, Mn), 2018-2029
Figure 25. Nordic Countries Anti-Camelid VHH Antibody Revenue, (US$, Mn), 2018-2029
Figure 26. Benelux Anti-Camelid VHH Antibody Revenue, (US$, Mn), 2018-2029
Figure 27. By Region - Asia Anti-Camelid VHH Antibody Revenue Market Share, 2018-2029
Figure 28. China Anti-Camelid VHH Antibody Revenue, (US$, Mn), 2018-2029
Figure 29. Japan Anti-Camelid VHH Antibody Revenue, (US$, Mn), 2018-2029
Figure 30. South Korea Anti-Camelid VHH Antibody Revenue, (US$, Mn), 2018-2029
Figure 31. Southeast Asia Anti-Camelid VHH Antibody Revenue, (US$, Mn), 2018-2029
Figure 32. India Anti-Camelid VHH Antibody Revenue, (US$, Mn), 2018-2029
Figure 33. By Country - South America Anti-Camelid VHH Antibody Revenue Market Share, 2018-2029
Figure 34. Brazil Anti-Camelid VHH Antibody Revenue, (US$, Mn), 2018-2029
Figure 35. Argentina Anti-Camelid VHH Antibody Revenue, (US$, Mn), 2018-2029
Figure 36. By Country - Middle East & Africa Anti-Camelid VHH Antibody Revenue Market Share, 2018-2029
Figure 37. Turkey Anti-Camelid VHH Antibody Revenue, (US$, Mn), 2018-2029
Figure 38. Israel Anti-Camelid VHH Antibody Revenue, (US$, Mn), 2018-2029
Figure 39. Saudi Arabia Anti-Camelid VHH Antibody Revenue, (US$, Mn), 2018-2029
Figure 40. UAE Anti-Camelid VHH Antibody Revenue, (US$, Mn), 2018-2029
Figure 41. Genscript Biotech Corporation Anti-Camelid VHH Antibody Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 42. Rockland Immunochemicals, Inc. Anti-Camelid VHH Antibody Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 43. ABclonal Anti-Camelid VHH Antibody Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 44. Eurogentec Anti-Camelid VHH Antibody Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 45. Jackson ImmunoResearch Anti-Camelid VHH Antibody Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 46. Southern Biotech Anti-Camelid VHH Antibody Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 47. LSBio Anti-Camelid VHH Antibody Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 48. Stratech Anti-Camelid VHH Antibody Revenue Year Over Year Growth (US$, Mn) & (2018-2023)



❖ 免責事項 ❖
http://www.globalresearch.jp/disclaimer
★リサーチレポート[ 抗ラクダ科VHH抗体の世界市場見通し2023年-2029年(Anti-Camelid VHH Antibody Market, Global Outlook and Forecast 2023-2029)]についてメールでお問い合わせはこちらでお願いします。
◆関連リサーチレポート◆
  • ウサギモノクローナル抗体の世界市場見通し2023年-2029年
  • KRT15抗体のグローバル市場展望 2023年-2029年：モノクローナル、ポリクローナル
  • 抗微生物ペプチドの世界市場見通し2023年-2029年
  • TCR抗体の世界市場見通し2023年-2029年
  • FMDV抗体検査キットのグローバル市場展望 2023年-2029年：FMD-Asia1-Ab、 FMD-O-Ab、 FMD-A-Ab、 その他

    • ◆H&Iグローバルリサーチのお客様（例）◆